TiVenture

TiVenture

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Switzerland, Lugano

About

The VC's location is in Europe, Switzerland. The the headquarters of this VC is in Lugano.

The country of its foundation and the country of its most frequent investments coincides - Switzerland. We can highlight the most popular investment areas for this fund, such as Analytics, Leisure. In addition, there are 8 more industries where it has achieved success. The average start-up age at the time of investment by this fund is 2-3. Among the most popular portfolio start-up of the fund, is Gain Therapeutics.

The fund typically invests in rounds with 2-3 participants. The fund often co-invests with VitaTech S.A, United Ventures, R-301 Capital. In subsequent rounds, the fund is usually joined by Rancilio Cube, R-301 Capital, Medra Capital.

At the time of investment by TiVenture, a typical start-up valuation would be 1-5 millions dollars. The most common rounds for this fund are in the range of 1 - 5 millions dollars. The fund typically enters into less than 2 deals annually. The fund's activity peaked in 2019. In real terms, this VC performs 47 percentage points more exits than other funds.

Fund Activity

Operative

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Funds Investing Together

VitaTech S.A, United Ventures, R-301 Capital

Funds Investing in Following
Rounds

Rancilio Cube, R-301 Capital, Medra Capital

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: